Ron Peck

Ron Peck currently serves as President and Principal Consultant at Veritas Oncology, LLC and Interim Chief Medical Officer at Ensem Therapeutics, both since August 2024. Additionally, Ron holds the position of Adjunct Assistant Professor at Yale Cancer Center since February 2021. Previously, Ron was Chief Medical Officer at Arvinas from July 2019 to April 2024, where leadership resulted in a clinical development organization of over 70 employees and significant growth in the clinical portfolio. Earlier roles included Senior Vice President at TESARO, Chief Medical Officer at Kolltan Pharmaceuticals, and Vice President at Bristol-Myers Squibb. Ron's academic background includes positions at the University of Virginia and extensive training at Georgetown University and Thomas Jefferson University, culminating in a Doctor of Medicine degree.